Five to seven years after breast cancer treatment, over a third of women (37%) report persistent pain
- Department of Nursing, Yale University, New Haven, Connecticut, USA
- Correspondence to: Professor Tish Knobf, Department of Nursing, Yale University, New Haven, CT 06536-0740, USA;
Implications for practice and research
Early detection and improvements in treatment have resulted in significantly improved survival of breast cancer survivors. This study highlights the importance of persistent and late effects of cancer therapy on the lives of survivors and identified fluctuating pattern of symptoms over time.
The findings of persistent pain and sensory disturbances at an average of 6 years following primary breast cancer therapy underscore the significance of long-term treatment effects.
Younger age and axillary lymph node dissection were reported as risk factors for persistent pain. Patients with these risk factors should be targeted in clinical practice for assessment and early intervention.
The study findings …